English
SpanishTrusted Resources: Education
Scientific literature and patient education texts
Early Diagnosis of Spinal Muscular Atrophy
source: Ugeskrift for laeger
year: 2021
authors: Born AP,Werlauff U
summary/abstract:Untreated spinal muscular atrophy (SMA) causes progressive motor impairment in affected children. Clinical trials of newly developed disease-modifying drugs have shown the greatest effect in young and in pre-symptomatic children as summarised in this review. An application for neonatal screening in Denmark is currently under consideration. Diagnosis and treatment of children with SMA is often delayed, and until a national screening becomes available, the only way to reduce diagnostic delay is to increase the awareness of medical staff and to make information on early signs of SMA available for concerned families.
organization: University of Copenhagen, Denmark; Aarhus University, Denmarkread more
BookmarkRelated Content
-
The SMA France National Registry: Already Encouraging ResultsSpinal muscular atrophy is a debilitatin...
-
FDA Lifts Partial Clinical Hold on Novartis’ SMA Drug ProgrammeThe US Food and Drug Administration (FDA...
-
Identification of Specific Gene Methylation Patterns During Motor Neuron Differentiation From Spinal Muscular Atroph...Spinal muscular atrophy is a progressive...
-
Biogen Exercises Option With Ionis to Develop and Commercialize Investigational ASO for SMABiogen, Inc. and Ionis Pharmaceuticals, ...
-
Genetic Testing for Spinal Muscular Atrophyhttps://www.youtube.com/watch?v=7x_bumsC...
-
SMA and Nusinersen (Spinraza) the Story so farhttps://slideplayer.com/slide/14664651/...
-
Spinal Muscular Atrophy: Types and GeneticsSpinal Muscular Atrophy (SMA)SMA is a ra...
Powered by
In partnership with
